Detalhe da pesquisa
1.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
N Engl J Med;
381(17): 1609-1620, 2019 10 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31475794
2.
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
Circulation;
141(5): 338-351, 2020 02 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31736337
3.
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
Eur Heart J;
38(15): 1132-1143, 2017 04 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28158398
4.
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
Circulation;
133(23): 2254-62, 2016 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27143684
5.
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
N Engl J Med;
371(11): 993-1004, 2014 Sep 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25176015
6.
The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
Am Heart J;
188: 35-41, 2017 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28577679
7.
Geographic variations in the PARADIGM-HF heart failure trial.
Eur Heart J;
37(41): 3167-3174, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27354044
8.
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Circulation;
131(1): 54-61, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25403646
9.
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.
Eur Heart J;
36(38): 2576-84, 2015 Oct 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26231885
10.
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.
Eur Heart J;
36(30): 1990-7, 2015 Aug 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26022006
11.
Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/Valsartan.
JACC Heart Fail;
11(7): 749-759, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37407154
12.
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
J Am Coll Cardiol;
80(12): 1130-1143, 2022 09 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36050227
13.
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.
Eur J Heart Fail;
24(3): 497-509, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34918855
14.
Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
JACC Heart Fail;
9(5): 374-382, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33839075
15.
Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
J Am Coll Cardiol;
77(16): 1961-1973, 2021 04 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33888245
16.
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
J Am Heart Assoc;
10(4): e019238, 2021 02 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33522249
17.
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Circ Heart Fail;
14(4): e007901, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33866828
18.
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
J Am Coll Cardiol;
76(5): 503-514, 2020 08 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32731928
19.
Volatility of elevated serum ferritin in anemic hemodialysis patients.
J Nephrol;
22(4): 553-60, 2009.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19662612
20.
Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.
J Am Soc Nephrol;
19(2): 372-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18216316